{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anti-inflammatory", "Ginseng", "Organ protection", "Sepsis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37252283", "DateRevised": {"Year": "2023", "Month": "05", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "05"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jgr.2022.05.003"], "Journal": {"ISSN": "1226-8453", "JournalIssue": {"Volume": "47", "Issue": "3", "PubDate": {"Year": "2023", "Month": "May"}}, "Title": "Journal of ginseng research", "ISOAbbreviation": "J Ginseng Res"}, "ArticleTitle": "Potential application of ginseng in sepsis:: Applications of ginseng in sepsis.", "Pagination": {"StartPage": "353", "EndPage": "358", "MedlinePgn": "353-358"}, "Abstract": {"AbstractText": ["Sepsis and septic shock affect millions of people worldwide each year with high clinical mortality rates. At present, basic research on sepsis has emerged in an endless stream, but there are few effective clinical translation results. Ginseng, a medicinal and edible representative of Araliaceae plants, contains a variety of biologically active compounds including ginsenosides, alkaloids, glycosides, polysaccharides, and polypeptides. Neuromodulation, anticancer activity, blood lipid regulation, and antithrombotic activity have been linked to ginseng treatment. At present, basic and clinical research have suggested various applications of ginseng in sepsis. In view of the different effects of various ginseng components on the pathogenesis of sepsis, and in order to further understand and develop the possible value of ginseng in sepsis, this manuscript reviews the application of various components of ginseng in the treatment of sepsis in recent years."], "CopyrightInformation": "\u00a9 2022 The Korean Society of Ginseng. Publishing services by Elsevier B.V."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of ICU, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China."}], "LastName": "Yang", "ForeName": "Fuxun", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of ICU, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China."}], "LastName": "Li", "ForeName": "Jiajia", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of ICU, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China."}], "LastName": "Lan", "ForeName": "Yunping", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of ICU, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China."}], "LastName": "Lei", "ForeName": "Yu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of ICU, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China."}], "LastName": "Zeng", "ForeName": "Fan", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of ICU, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China."}], "LastName": "Huang", "ForeName": "Xiaobo", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of ICU, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China."}], "LastName": "Luo", "ForeName": "Xiaoxiu", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of ICU, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China."}], "LastName": "Liu", "ForeName": "Rongan", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Korea (South)", "MedlineTA": "J Ginseng Res", "NlmUniqueID": "100890690", "ISSNLinking": "1226-8453"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Evans L., Rhodes A., Alhazzani W., Antonelli M., Coopersmith C.M., French C., Machado F.R., McIntyre L., Ostermann M., Prescott H.C., et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u20131247.", "ArticleIdList": ["PMC8486643", "34599691"]}, {"Citation": "Gentile L.F., Moldawer L.L. HMGB1 as a therapeutic target for sepsis: it's all in the timing! Expert Opin Ther Targets. 2014;18(3):243\u2013245.", "ArticleIdList": ["PMC5119516", "24479494"]}, {"Citation": "Deutschman C.S., Hellman J. Ferrer roca R, de backer D, coopersmith CM: the surviving sepsis campaign: basic/translational science research priorities. Crit Care Med. 2020;48(8):1217\u20131232.", "ArticleIdList": ["PMC7365680", "32697495"]}, {"Citation": "Ru W., Wang D., Xu Y., He X., Sun Y.E., Qian L., Zhou X., Qin Y. Chemical constituents and bioactivities of Panax ginseng (C. A. Mey.) Drug Discov Ther. 2015;9(1):23\u201332.", "ArticleIdList": ["25788049"]}, {"Citation": "van der Poll T., van de Veerdonk F.L., Scicluna B.P., Netea M.G. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17(7):407\u2013420.", "ArticleIdList": ["28436424"]}, {"Citation": "Xu H.L., Chen G.H., Wu Y.T., Xie L.P., Tan Z.B., Liu B., Fan H.J., Chen H.M., Huang G.Q., Liu M., et al. Ginsenoside Ro, an oleanolic saponin of Panax ginseng, exerts anti-inflammatory effect by direct inhibiting toll like receptor 4 signaling pathway. J\u00a0Ginseng Res. 2022;46(1):156\u2013166.", "ArticleIdList": ["PMC8753525", "35058732"]}, {"Citation": "Kim M.K., Kang H., Baek C.W., Jung Y.H., Woo Y.C., Choi G.J., Shin H.Y., Kim K.S. Antinociceptive and anti-inflammatory effects of ginsenoside Rf in a rat model of incisional pain. J\u00a0Ginseng Res. 2018;42(2):183\u2013191.", "ArticleIdList": ["PMC5925619", "29719465"]}, {"Citation": "Yoon S.J., Park J.Y., Choi S., Lee J.B., Jung H., Kim T.D., Yoon S.R., Choi I., Shim S., Park Y.J. Ginsenoside Rg3 regulates S-nitrosylation of the NLRP3 inflammasome via suppression of iNOS. Biochem Biophys Res Commun. 2015;463(4):1184\u20131189.", "ArticleIdList": ["26086107"]}, {"Citation": "Shi Y., Wang H., Zheng M., Xu W., Yang Y., Shi F. Ginsenoside Rg3 suppresses the NLRP3 inflammasome activation through inhibition of its assembly. Faseb J. 2020;34(1):208\u2013221.", "ArticleIdList": ["31914640"]}, {"Citation": "Yayeh T., Jung K.H., Jeong H.Y., Park J.H., Song Y.B., Kwak Y.S., Kang H.S., Cho J.Y., Oh J.W., Kim S.K., et al. Korean red ginseng saponin fraction downregulates proinflammatory mediators in LPS stimulated RAW264.7 cells and protects mice against endotoxic shock. J\u00a0Ginseng Res. 2012;36(3):263\u2013269.", "ArticleIdList": ["PMC3659593", "23717127"]}, {"Citation": "Yang C.S., Ko S.R., Cho B.G., Shin D.M., Yuk J.M., Li S., Kim J.M., Evans R.M., Jung J.S., Song D.K., et al. The ginsenoside metabolite compound K, a novel agonist of glucocorticoid receptor, induces tolerance to endotoxin-induced lethal shock. J\u00a0Cell Mol Med. 2008;12(5a):1739\u20131753.", "ArticleIdList": ["PMC3918090", "18053081"]}, {"Citation": "Wu L.L., Jia B.H., Sun J., Chen J.X., Liu Z.Y., Liu Y. Protective effects of ginsenoside Rb1 on septic rats and its mechanism. Biomed Environ Sci. 2014;27(4):300\u2013303.", "ArticleIdList": ["24758759"]}, {"Citation": "Hur J., Lee H.G., Kim E., Won J.P., Cho Y., Choi M.J., Lee H., Seo H.G. Ginseng leaf extract ameliorates the survival of endotoxemic mice by inhibiting the release of high mobility group box 1. J\u00a0Food Biochem. 2021;45(7):e13805.", "ArticleIdList": ["34096077"]}, {"Citation": "Kim J.E., Lee W., Yang S., Cho S.H., Baek M.C., Song G.Y., Bae J.S. Suppressive effects of rare ginsenosides, Rk1 and Rg5, on HMGB1-mediated septic responses. Food Chem Toxicol. 2019;124:45\u201353.", "ArticleIdList": ["30496780"]}, {"Citation": "Huynh D.T.N., Baek N., Sim S., Myung C.S., Heo K.S. Minor ginsenoside Rg2 and Rh1 attenuates LPS-induced acute liver and kidney damages via downregulating activation of TLR4-STAT1 and inflammatory cytokine production in macrophages. Int J Mol Sci. 2020;21(18)", "ArticleIdList": ["PMC7555743", "32932915"]}, {"Citation": "Su F., Xue Y., Wang Y., Zhang L., Chen W., Hu S. Protective effect of ginsenosides Rg1 and Re on lipopolysaccharide-induced sepsis by competitive binding to Toll-like receptor 4. Antimicrob Agents Chemother. 2015;59(9):5654\u20135663.", "ArticleIdList": ["PMC4538534", "26149990"]}, {"Citation": "Lim J.-K., Kang H.-J., Kang S.-N., Lee B.-Y. Antioxidant and antimicrobial activities of various solvent fractions of fine ginseng root. Food Sci Biotechnol. 2009;18(2):513\u2013518."}, {"Citation": "Xu L.-L., Han T., Wu J.-Z., Zhang Q.-Y., Zhang H., Huang B.-K., Rahman K., Qin L.-P. Comparative research of chemical constituents, antifungal and antitumor properties of ether extracts of Panax ginseng and its endophytic fungus. Phytomedicine. 2009;16(6\u20137):609\u2013616.", "ArticleIdList": ["19403293"]}, {"Citation": "Ahn J.Y., Song J.Y., Yun Y.S., Jeong G., Choi I.S. Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan. FEMS Immunol Med Microbiol. 2006;46(2):187\u2013197.", "ArticleIdList": ["16487300"]}, {"Citation": "Lim D.S., Bae K.G., Jung I.S., Kim C.H., Yun Y.S., Song J.Y. Anti-septicaemic effect of polysaccharide from Panax ginseng by macrophage activation. J\u00a0Infect. 2002;45(1):32\u201338.", "ArticleIdList": ["12217729"]}, {"Citation": "Nguyen C.T., Luong T.T., Lee S.Y., Kim G.L., Kwon H., Lee H.G., Park C.K., Rhee D.K. Panax ginseng aqueous extract prevents pneumococcal sepsis in\u00a0vivo by potentiating cell survival and diminishing inflammation. Phytomedicine. 2015;22(11):1055\u20131061.", "ArticleIdList": ["26407948"]}, {"Citation": "Venet F., Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2018;14(2):121\u2013137.", "ArticleIdList": ["29225343"]}, {"Citation": "Gupta D.L., Bhoi S., Mohan T., Galwnkar S., Rao D.N. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with post traumatic sepsis. Cytokine. 2016;88:214\u2013221.", "ArticleIdList": ["27676155"]}, {"Citation": "Bae J., Koo J., Kim S., Park T.Y., Kim M.Y. Ginsenoside Rp1 exerts anti-inflammatory effects via activation of dendritic cells and regulatory T. Cells. J Ginseng Res. 2012;36(4):375\u2013382.", "ArticleIdList": ["PMC3659614", "23717139"]}, {"Citation": "Zou Y., Tao T., Tian Y., Zhu J., Cao L., Deng X., Li J. Ginsenoside Rg1 improves survival in a murine model of polymicrobial sepsis by suppressing the inflammatory response and apoptosis of lymphocytes. J\u00a0Surg Res. 2013;183(2):760\u2013766.", "ArticleIdList": ["23478085"]}, {"Citation": "Ehrman R.R., Sullivan A.N., Favot M.J., Sherwin R.L., Reynolds C.A., Abidov A., Levy P.D. Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature. Crit Care. 2018;22(1):112.", "ArticleIdList": ["PMC5934857", "29724231"]}, {"Citation": "L'Heureux M., Sternberg M., Brath L., Turlington J., Kashiouris M.G. Sepsis-induced cardiomyopathy: a comprehensive review. Curr Cardiol Rep. 2020;22(5):35.", "ArticleIdList": ["PMC7222131", "32377972"]}, {"Citation": "Wu Y., Qin C., Lu X., Marchiori J., Feng Q. North American ginseng inhibits myocardial NOX2-ERK1/2 signaling and tumor necrosis factor-\u03b1 expression in endotoxemia. Pharmacol Res. 2016;111:217\u2013225.", "ArticleIdList": ["27317946"]}, {"Citation": "Luo M., Yan D., Sun Q., Tao J., Xu L., Sun H., Zhao H. Ginsenoside Rg1 attenuates cardiomyocyte apoptosis and inflammation via the TLR4/NF-kB/NLRP3 pathway. J\u00a0Cell Biochem. 2020;121(4):2994\u20133004.", "ArticleIdList": ["31709615"]}, {"Citation": "Lopez R., Rello J., Taccone F.S., Salem O.B.H., Bauer P.R., S\u00e9guin A., van de Louw A., Metaxa V., Klouche K., Martin Loeches I., et al. Aminoglycosides in immunocompromised critically ill patients with bacterial pneumonia and septic shock: a post-hoc analysis of a prospective multicenter multinational cohort. Shock. 2020;54(6):731\u2013737.", "ArticleIdList": ["32496415"]}, {"Citation": "Liu Z., Pan H., Zhang Y., Zheng Z., Xiao W., Hong X., Chen F., Peng X., Pei Y., Rong J., et al. Ginsenoside-Rg1 attenuates sepsis-induced cardiac dysfunction by modulating mitochondrial damage via the P2X7 receptor-mediated Akt/GSK-3\u03b2 signaling pathway. J\u00a0Biochem Mol Toxicol. 2022;36(1):e22885.", "ArticleIdList": ["34859534"]}, {"Citation": "Chen R.C., Wang J., Yang L., Sun G.B., Sun X.B. Protective effects of ginsenoside Re on lipopolysaccharide-induced cardiac dysfunction in mice. Food Funct. 2016;7(5):2278\u20132287.", "ArticleIdList": ["27074714"]}, {"Citation": "Yao Y.M., Zhang H. Better therapy for combat injury. Mil Med Res. 2019;6(1):23.", "ArticleIdList": ["PMC6657202", "31340864"]}, {"Citation": "Hwang J.W., Yao H., Caito S., Sundar I.K., Rahman I. Redox regulation of SIRT1 in inflammation and cellular senescence. Free Radic Biol Med. 2013;61:95\u2013110.", "ArticleIdList": ["PMC3762912", "23542362"]}, {"Citation": "Xie J., Zhang X., Zhang L. Negative regulation of inflammation by SIRT1. Pharmacol Res. 2013;67(1):60\u201367.", "ArticleIdList": ["23098819"]}, {"Citation": "Wang Q.L., Yang L., Peng Y., Gao M., Yang M.S., Xing W., Xiao X.Z. Ginsenoside Rg1 regulates SIRT1 to ameliorate sepsis-induced lung inflammation and injury via inhibiting endoplasmic reticulum stress and inflammation. Mediat Inflamm. 2019;2019:6453296.", "ArticleIdList": ["PMC6409002", "30918470"]}, {"Citation": "Yuan Q., Jiang Y.W., Ma T.T., Fang Q.H., Pan L. Attenuating effect of Ginsenoside Rb1 on LPS-induced lung injury in rats. J\u00a0Inflamm. 2014;11(1):40.", "ArticleIdList": ["PMC4272525", "25530718"]}, {"Citation": "Dal-Secco D., Freitas A., Abreu M.A., Garlet T.P., Rossi M.A., Ferreira S.H., Silva J.S., Alves-Filho J.C., Cunha F.Q. Reduction of ICAM-1 expression by carbon monoxide via soluble guanylate cyclase activation accounts for modulation of neutrophil migration. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. 2010;381(6):483\u2013493.", "ArticleIdList": ["20349048"]}, {"Citation": "Poston J.T., Koyner J.L. Sepsis associated acute kidney injury. BMJ. 2019;364:k4891.", "ArticleIdList": ["PMC6890472", "30626586"]}, {"Citation": "Chen Y., Du Y., Li Y., Wang X., Gao P., Yang G., Fang Y., Meng Y., Zhao X., Saponin Panaxadiol, Improve Dexamethasone. Renal function in lipopolysaccharide-induced mouse model of acute kidney injury. PLoS One. 2015;(7):10. e0134653.", "ArticleIdList": ["PMC4521715", "26230340"]}, {"Citation": "Gao H., Kang N., Hu C., Zhang Z., Xu Q., Liu Y., Yang S. Ginsenoside Rb1 exerts anti-inflammatory effects in\u00a0vitro and in\u00a0vivo by modulating toll-like receptor 4 dimerization and NF-kB/MAPKs signaling pathways. Phytomedicine. 2020;69:153197.", "ArticleIdList": ["32146298"]}, {"Citation": "Wu T., Wang L., An J., Wu C.Y., Wang Y., Qian L., Zhou J., Zhang Y.L., Zhou Q.Q., Wang X.H., et al. Noninvasive imaging of stored red blood cell-transfusion aggravating sepsis-induced liver injury associated with increased activation of M1-polarized kupffer cells. Shock. 2017;48(4):459\u2013466.", "ArticleIdList": ["PMC5571877", "28333715"]}, {"Citation": "Bakalli I. Liver dysfunction in severe sepsis from respiratory syncytial virus. J\u00a0Pediatr Intensive Care. 2018;7(2):110\u2013114.", "ArticleIdList": ["PMC6260355", "31073482"]}, {"Citation": "Feng H., Chen J., Wang H., Cheng Y., Zou Z., Zhong Q., Xu J. Roflumilast reverses polymicrobial sepsis-induced liver damage by inhibiting inflammation in mice. Lab Invest. 2017;97(9):1008\u20131019.", "ArticleIdList": ["28650427"]}, {"Citation": "Crager S. Critically ill patients with end-stage liver disease. Emerg Med Clin. 2019;37(3):511\u2013527.", "ArticleIdList": ["31262418"]}, {"Citation": "Kurland S., Furebring M., L\u00f6wdin E., Eliasson E., Nielsen E.I., Sj\u00f6lin J. Pharmacokinetics of caspofungin in critically ill patients in relation to liver dysfunction: differential impact of plasma albumin and bilirubin levels. Antimicrob Agents Chemother. 2019;(6):63.", "ArticleIdList": ["PMC6535551", "30962329"]}, {"Citation": "Dai Y.W., Zhang C.C., Zhao H.X., Wan J.Z., Deng L.L., Zhou Z.Y., Dun Y.Y., Liu C.Q., Yuan D., Wang T. Chikusetsusaponin V attenuates lipopolysaccharide-induced liver injury in mice. Immunopharmacol Immunotoxicol. 2016;38(3):167\u2013174.", "ArticleIdList": ["26981791"]}, {"Citation": "Nguyen T.L.L., Huynh D.T.N., Jin Y., Jeon H., Heo K.S. Protective effects of ginsenoside-Rg2 and -Rh1 on liver function through inhibiting TAK1 and STAT3-mediated inflammatory activity and Nrf2/ARE-mediated antioxidant signaling pathway. Arch Pharm Res (Seoul) 2021;44(2):241\u2013252.", "ArticleIdList": ["33537886"]}, {"Citation": "Xing W., Yang L., Peng Y., Wang Q., Gao M., Yang M., Xiao X. Ginsenoside Rg3 attenuates sepsis-induced injury and mitochondrial dysfunction in liver via AMPK-mediated autophagy flux. Biosci Rep. 2017;(4):37.", "ArticleIdList": ["PMC5577177", "28779013"]}, {"Citation": "Stubbs D.J., Yamamoto A.K., Menon D.K. Imaging in sepsis-associated encephalopathy\u2013insights and opportunities. Nat Rev Neurol. 2013;9(10):551\u2013561.", "ArticleIdList": ["23999468"]}, {"Citation": "Kafa I.M., Bakirci S., Uysal M., Kurt M.A. Alterations in the brain electrical activity in a rat model of sepsis-associated encephalopathy. Brain Res. 2010;1354:217\u2013226.", "ArticleIdList": ["20674556"]}, {"Citation": "Li Y., Wang F., Luo Y. Ginsenoside Rg1 protects against sepsis-associated encephalopathy through beclin 1-independent autophagy in mice. J\u00a0Surg Res. 2017;207:181\u2013189.", "ArticleIdList": ["27979475"]}, {"Citation": "Mei X., Feng H., Shao B. Alleviation of sepsis-associated encephalopathy by ginsenoside via inhibition of oxidative stress and cell apoptosis: an experimental study. Pak J Pharm Sci. 2020;33(6):2567\u20132577.", "ArticleIdList": ["33867332"]}, {"Citation": "Kang A., Xie T., Zhu D., Shan J., Di L., Zheng X. Suppressive effect of ginsenoside Rg3 against lipopolysaccharide-induced depression-like behavior and neuroinflammation in mice. J\u00a0Agric Food Chem. 2017;65(32):6861\u20136869.", "ArticleIdList": ["28762741"]}, {"Citation": "Ma S., Evans R.G., Iguchi N., Tare M., Parkington H.C., Bellomo R., May C.N., Lankadeva Y.R. Sepsis-induced acute kidney injury: a disease of the microcirculation. Microcirculation. 2019;26(2):e12483.", "ArticleIdList": ["29908046"]}, {"Citation": "Chen G.Y., Chen X., King S., Cavassani K.A., Cheng J., Zheng X., Cao H., Yu H., Qu J., Fang D., et al. Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction. Nat Biotechnol. 2011;29(5):428\u2013435.", "ArticleIdList": ["PMC4090080", "21478876"]}, {"Citation": "Blikslager A.T., Moeser A.J., Gookin J.L., Jones S.L., Odle J. Restoration of barrier function in injured intestinal mucosa. Physiol Rev. 2007;87(2):545\u2013564.", "ArticleIdList": ["17429041"]}, {"Citation": "Mittal R., Coopersmith C.M. Redefining the gut as the motor of critical illness. Trends Mol Med. 2014;20(4):214\u2013223.", "ArticleIdList": ["PMC3959633", "24055446"]}, {"Citation": "Adiliaghdam F., Cavallaro P., Mohad V., Almpani M., K\u00fchn F., Gharedaghi M.H., Najibi M., Rahme L.G., Hodin R.A. Targeting the gut to prevent sepsis from a cutaneous burn. JCI Insight. 2020;(19):5.", "ArticleIdList": ["PMC7566703", "33004693"]}, {"Citation": "Haussner F., Chakraborty S., Halbgebauer R., Huber-Lang M. Challenge to the intestinal mucosa during sepsis. Front Immunol. 2019;10:891.", "ArticleIdList": ["PMC6502990", "31114571"]}, {"Citation": "Lee W., Cho S.H., Kim J.E., Lee C., Lee J.H., Baek M.C., Song G.Y., Bae J.S. Suppressive effects of ginsenoside Rh1 on HMGB1-mediated septic responses. Am J Chin Med. 2019;47(1):119\u2013133.", "ArticleIdList": ["30630344"]}, {"Citation": "Zhang Y., Sun K., Liu Y.Y., Zhang Y.P., Hu B.H., Chang X., Yan L., Pan C.S., Li Q., Fan J.Y., et al. Ginsenoside Rb1 ameliorates lipopolysaccharide-induced albumin leakage from rat mesenteric venules by intervening in both trans- and paracellular pathway. Am J Physiol Gastrointest Liver Physiol. 2014;306(4):G289\u2013G300.", "ArticleIdList": ["24356882"]}, {"Citation": "Zhang N., Liu J., Qiu Z., Ye Y., Zhang J., Lou T. Shenfu injection for improving cellular immunity and clinical outcome in patients with sepsis or septic shock. Am J Emerg Med. 2017;35(1):1\u20136.", "ArticleIdList": ["28029485"]}, {"Citation": "Li M.Q., Pan C.G., Wang X.M., Mo X., Shi Z.X., Xu J.Y., Xu Y.J., Han G.J. Effect of the Shenfu injection combined with early goal-directed therapy on organ functions and outcomes of septic shock patients. Cell Biochem Biophys. 2015;72(3):807\u2013812.", "ArticleIdList": ["25680826"]}, {"Citation": "Li Y., Zhang X., Lin P., Qiu H., Wei J., Cao Y., Pan S., Walline J., Qian C., Shan Z., et al. Effects of Shenfu injection in the treatment of septic shock patients: a multicenter, controlled, randomized, open-label trial. Evid Base Compl Alternat Med. 2016;2016:2565169.", "ArticleIdList": ["PMC4944053", "27446222"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "15"}, {"Year": "2022", "Month": "4", "Day": "11"}, {"Year": "2022", "Month": "5", "Day": "2"}, {"Year": "2023", "Month": "5", "Day": "30", "Hour": "13", "Minute": "8"}, {"Year": "2023", "Month": "5", "Day": "30", "Hour": "13", "Minute": "7"}, {"Year": "2023", "Month": "5", "Day": "30", "Hour": "11", "Minute": "52"}, {"Year": "2022", "Month": "5", "Day": "5"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37252283", "PMC10214126", "10.1016/j.jgr.2022.05.003", "S1226-8453(22)00062-8"]}}], "PubmedBookArticle": []}